← Back to Search

Genetic Testing Education for Cancer Risk (GeneBOPP Trial)

Waitlist Available
Led By Huma Rana, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

GeneBOPP Trial Summary

This trial is testing whether two different ways of providing information to people considering genetic testing for cancer risk affects how likely they are to get the test.

Who is the study for?
This trial is for adults over 18 with breast, ovarian, pancreatic, or metastatic prostate cancer who haven't had genetic testing for cancer before. They must understand English well enough to consent and can't be pregnant or imprisoned.Check my eligibility
What is being tested?
The study compares two ways of educating people about genetic testing for hereditary cancers: one group will receive standard genetic counseling and the other will watch an educational video.See study design
What are the potential side effects?
Since this trial involves education methods rather than medical treatments, there are no direct side effects from interventions like drugs or surgery. However, learning about cancer risks may cause emotional or psychological impact.

GeneBOPP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of patients who have germline genetic tests
Secondary outcome measures
Cascade testing in positives
Decisional Regret
Family communication of genetic test results
+6 more

GeneBOPP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group B: Educational videoExperimental Treatment1 Intervention
Will watch a brief educational video that is approximately 8 minutes in length about the genetic testing process and what to expect prior to genetic testing.
Group II: Group A: Standard genetic counselingActive Control1 Intervention
Will receive standard genetic counseling prior to genetic testing.
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Video

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,083 Previous Clinical Trials
341,462 Total Patients Enrolled
40 Trials studying Ovarian Cancer
4,383 Patients Enrolled for Ovarian Cancer
Ambry GeneticsIndustry Sponsor
3 Previous Clinical Trials
485 Total Patients Enrolled
Huma Rana, MD5.05 ReviewsPrincipal Investigator - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
5Patient Review
Dr. Rana is an excellent caretaker, especially for those with a genetic disposition for cancer. She is very knowledgeable and takes her time with each patient to ensure they feel comfortable and confident.

Media Library

Educational Video Clinical Trial Eligibility Overview. Trial Name: NCT04330716 — N/A
Ovarian Cancer Research Study Groups: Group B: Educational video, Group A: Standard genetic counseling
Ovarian Cancer Clinical Trial 2023: Educational Video Highlights & Side Effects. Trial Name: NCT04330716 — N/A
Educational Video 2023 Treatment Timeline for Medical Study. Trial Name: NCT04330716 — N/A
~60 spots leftby Jun 2025